Randomized trial demonstrates effective prediction of PTM sites using multi-modal deep learning, implying advancements in functional annotation.
Post-translational modifications are important for regulating cellular functions. Although traditional experimental methods accurately identify PTM sites, they are time-consuming. In this study, we propose a novel model capable of predicting 17 types of PTMs through multi-modal integration and AlphaFold predictions. Our model employs an enhanced CNN-transformer architecture to capture local dependencies within the sequence, while incorporating structural features and evolutionary patterns to effectively capture complex spatial relationships and global contextual dependencies. Through rigorous cross-validation and testing, our model demonstrates exceptional performance, achieving area under the curve scores of 96.5%, 91.6%, 91.0%, and 89.5% for the prediction of hydroxylation, malonylation, O-linked glycosylation, and phosphorylation, respectively. Notably, our model accurately identified known phosphorylation sites on tau and two recently identified residues linked to pre-tangle stages and early Alzheimer’s disease pathology. This work not only deepens the understanding of PTMs but also holds promise for advancing future research in the prediction of PTM sites and functional annotation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: